Oncology Research and Treatment

Hass H.G.a,b,c· Herzberger A.a,b,d· Wöckel A.e· Stepien J.a,b,d

Author affiliations

aAbt. Onkologie, Klinik Gais, Gais, Switzerland
bDep. Innere Medizin, Klinik Gais, Gais, Switzerland
cInstitut für Rehabilitrationsforschung und Survivorship (IREFOS), Scheidegg, Germany
dParacelsus-Klinik, Scheidegg, Germany
eFrauenklinik, Universitätsklinikum, Würzburg, Germany

Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Access via DeepDyve Unlimited fulltext viewing Of this article Organize, annotate And mark up articles Printing And downloading restrictions apply

Select

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

Received: February 18, 2022
Accepted: August 15, 2022
Published online: October 20, 2022

Number of Print Pages: 7
Number of Figures: 1
Number of Tables: 4

ISSN: 2296-5270 (Print)
eISSN: 2296-5262 (Online)

For additional information: https://www.karger.com/ORT

Abstract

Introduction: Male breast cancer (MBC) is a rare malignancy that accounts for less than 1% of all cancers in men and less than 1% of all breast cancers worldwide. Understandably, due to the low incidence of this rare cancer, there is a lack of prospective clinical data. The aim of this retrospective study was the analysis of therapy-induced toxicities as well as the assessment of psychological distress in the affected men during oncological inpatient rehabilitation. Methods: Fifty-one MBC patients were evaluated for the presence of treatment-induced side effects, toxicities, and psychological distress (using German version of the 11-stage NCCN distress thermometer; cut-off ≥5) during oncological indoor rehabilitation. The collected data were checked for correlation with sociodemographic and clinical factors (SPSS 22). Results: The mean age was 62.0 ± 10.6 years, in 96% a hormone-dependent breast tumor (ER+), and in over 75%, overweight or obesity (BMI >25/>30) was diagnosed. Most reported side effects included weakness/fatigue (74.5%), arthralgia after surgery/chemotherapy (43.1%), chemotherapy-induced polyneuropathy (36.3%), and/or lymphedema (13.7%). Psychological distress was detected in 24 cases (47.0%; ≥5), in 13 cases even with significantly high levels (25.5%; ≥7). There was no correlation between psychological distress and clinical factors such as age, performed treatment (e.g., chemotherapy), or therapy-induced side effects (e.g., lymphedema) in our small collective. Conclusions: Psychological distress and somatic side effects are common in MBC. These data demonstrate the importance of routine screening for psychological distress and the high need for psycho-oncological therapy (regardless of gender) in multimodal oncological rehabilitation.

© 2022 S. Karger AG, Basel

References Abdelwahab Yousef AJ. Male breast cancer: epidemiology and risk factors. Semin Oncol. 2017;44(4):267–72. Gucalp A, Traina TA, Eisner JR, Parker JS, Selitsky SR, Park BH, et al. Male breast cancer: a disease distinct from female breast cancer. Breast Cancer Res Treat. 2019;173(1):37–48. Würstlein R, Hesse A, König A, Schulte-Vorwick F, Schrodi S, Ditsch N, et al. [Breast cancer in male]. MMW Fortschr Med. 2017;159(21–22):67–72. Ruddy KJ, Winer EP. Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship. Ann Oncol. 2013;24(6):1434–43. Lecarpentier J, Silvestri V, Kuchenbaecker KB, Barrowdale D, Dennis J, McGuffog L, et al. Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores. J Clin Oncol. 2017;35(20):2240–250. Ibrahim M, Yadav S, Ogunleye F, Zakalik D. Male BRCA mutation carriers: clinical characteristics and cancer spectrum. BMC Cancer. 2018;18(1):179. Hass HG, Seywald M, Stepien J, Muco B, Tanriverdi M, Beckmann MW, et al. [Early and late toxicities and socio-medical relevant disorders after oncological treatment for breast cancer-implications and assessment of rehabilitation requirement]. Rehabilitation. 2021;60(2):77–85. Ruddy KJ, Giobbie-Hurder A, Giordano SH, Goldfarb S, Kereakoglow S, Winer EP, et al. Quality of life and symptoms in male breast cancer survivors. The Breast. 2013;22(2):197–9. Schubart JR, Emerich M, Farnan M, Stanley Smith J, Kauffman GL, Kass RB. Screening for psychological distress in surgical breast cancer patients. Ann Surg Oncol. 2014;21(10):3348–53. Mehnert A, Hartung TJ, Friedrich M, Vehling S, Brahler E, Harter M, et al. One in two cancer patients is significantly distressed: prevalence and indicators of distress. Psychooncology. 2018;27(1):75–82. Brown KW, Levy AR, Rosberger Z, Edgar L. Psychological distress and cancer survival: a follow-up 10 years after diagnosis. Psychosom Med. 2003;65(4):636–43. Mehnert A, Brahler E, Faller H, Harter M, Keller M, Schulz H, et al. Four-week prevalence of mental disorders in patients with cancer across major tumor entities. J Clin Oncol. 2014;32(31):3540–6. Cutillo A, O’Hea E, Person S, Lessard D, Harralson T, Boudreaux E. The distress thermometer: cutoff points and clinical use. Oncol Nurs Forum. 2017;44(3):329–36. Mehnert A, Müller D, Lehmann C, Koch U. Die deutsche Version des NCCN Distress-Thermometers. Empirische Prüfung eines Screening-Instruments zur Erfassung psychosozialer Belastung bei Krebspatienten. Z Klin Psychol Psychiatr Psychother. 2006;54(3):213–23. Fauser D, Wienert J, Zomorodbakhsch B, Schmielau J, Biester I, Krüger HU, et al. Work-related medical rehabilitation in cancer: a cluster-randomized multicenter study. Dtsch Arztebl Int. 2019;116(35–36):592–9. Ullrich A, Rath HM, Otto U, Kerschgens C, Raida M, Hagen-Aukamp C, et al. Return to work in prostate cancer survivors: findings from a prospective study on occupational reintegration following a cancer rehabilitation program. BMC Cancer. 2018;18(1):751. Desai K, Mao JJ, Su I, Demichele A, Li Q, Xie SX, et al. Prevalence and risk factors for insomnia among breast cancer patients on aromatase inhibitors. Support Care Cancer. 2013;21(1):43–51. Kwak A, Jacobs J, Haggett D, Jimenez R, Peppercorn J. Evaluation and management of insomnia in women with breast cancer. Breast Cancer Res Treat. 2020;181(2):269–77. Ciambella CC, Taneja C, Dizon DS, Wiggins DL, Emmick CM, Leonard KL, et al. Distress: characterizing what causes the thermometer to shift in patients with newly diagnosed breast cancer attending a multidisciplinary clinic. Ann Surg Oncol. 2019;26(10):3204–9. Perez-Tejada J, Labaka A, Pascual-Sagastizabal E, Garmendia L, Iruretagoyena A, Arregi A. Predictors of psychological distress in breast cancer survivors: a biopsychosocial approach. Eur J Cancer Care. 2019;28:e13166. Hass HG, Seywald M, Wöckel A, Muco B, Tanriverdi M, Stepien J. Psychological distress in breast cancer patients during oncological inpatient rehabilitation: incidence, triggering factors and correlation with treatment-induced side effects. Arch Gynecol Obstet. 2022 Jun 22. Epub ahead of print. Yadav BS, Sharma SC, Singh R, Dahiya D, Ghoshal S. Male breast cancer: Outcome with adjuvant treatment. J Cancer Res Ther. 2020;16(6):1287–93. Giordano S, Schroder C, Poncet C, van Leeuwen-Stok E, Linderholm B, Abreu MH, et al. Clinical and biological characterization of male breast cancer (MBC) EORTC 10085/TBCRC023: baseline results from the prospective registry. Presented at the 2017 San Antonio Breast Cancer Symposium December 5–9 2017. San Antonio, TX, USA Poster P5–23-01; 2017. Schienkiewitz A, Mensink GBM, Kuhnert R, et al. Übergewicht und Adipositas bei Erwachsenen in Deutschland. J Health Monit. 2017;2(2):21–8. Richter A, Schienkiewitz A, Starker A, Krug S, Domanska O, Kuhnert R, et al. Health-promoting behaviour among adults in Germany: results from GEDA 2019/2020-EHIS. J Health Monit. 2021;6(3):26–44. Article / Publication Details

Received: February 18, 2022
Accepted: August 15, 2022
Published online: October 20, 2022

Number of Print Pages: 7
Number of Figures: 1
Number of Tables: 4

ISSN: 2296-5270 (Print)
eISSN: 2296-5262 (Online)

For additional information: https://www.karger.com/ORT

Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.